Oppenheimer Holdings Stock News

Oppenheimer initiated cover Latest Ratings for ACST Date Firm Action From To Dec 2021 Oppenheimer Initiates Coverage On Outperform Dec 2021 Oppenheimer Initiates Coverage Full story available on Benzinga.com

Global Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts at Oppenheimer dropped their Q1 2022 earnings estimates for Global Blood Therapeutics in a report issued on Monday, December 20th. Oppenheimer analyst M. Breidenbach now expects that the company will post earnings of ($1.07) per share for the quarter, down from their previous forecast of ($1.03). Oppenheimer also []

According to the head of technical analysis at Oppenheimer, the second A in FAANG requires closer attention among the other FAANG stocks.

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price objective hoisted by Royal Bank of Canada from $32.00 to $34.00 in a research note released on Tuesday, Price Targets.com reports. Royal Bank of Canada currently has an outperform rating on the biopharmaceutical companys stock. A number of other research analysts also recently issued reports on ACAD. Oppenheimer boosted [] The post ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Increased to $34.00 by Analysts at Royal Bank of Canada appeared first on ETF Daily News .

FedEx Co. (NYSE:FDX) Equities researchers at Oppenheimer increased their Q3 2022 EPS estimates for FedEx in a note issued to investors on Friday, December 17th. Oppenheimer analyst S. Schneeberger now expects that the shipping service provider will post earnings of $4.68 per share for the quarter, up from their prior forecast of $4.59. Oppenheimer [] The post Q3 2022 Earnings Estimate for FedEx Co. Issued By Oppenheimer (NYSE:FDX) appeared first on ETF Daily News .

WW International, Inc. (NASDAQ:WW) Stock analysts at Oppenheimer issued their Q4 2021 earnings per share estimates for WW International in a research note issued to investors on Thursday, December 16th. Oppenheimer analyst B. Nagel expects that the company will earn $0.32 per share for the quarter. Oppenheimer also issued estimates for WW Internationals FY2023 []

Nordson Co. - Oppenheimer upped their Q1 2022 earnings estimates for Nordson in a research note issued to investors on Thursday, December 16th. Oppenheimer analyst C. Glynn now

Freshpet (NASDAQ:FRPT) had its target price cut by equities research analysts at Oppenheimer from $175.00 to $120.00 in a research note issued on Monday, Price Targets.com reports. The firm currently has an outperform rating on the stock. Oppenheimers price target points to a potential upside of 23.46% from the companys previous close. Other research analysts []

WW International, Inc. (NASDAQ:WW) Oppenheimer issued their Q4 2021 earnings per share estimates for shares of WW International in a report issued on Thursday, December 16th. Oppenheimer analyst B. Nagel forecasts that the company will post earnings of $0.32 per share for the quarter. Oppenheimer also issued estimates for WW Internationals FY2023 earnings at []

Equities researchers at Oppenheimer initiated coverage on shares of Local Bounti (NYSE:LOCL) in a note issued to investors on Tuesday, The Fly reports. The firm set an outperform rating on the stock. Separately, Roth Capital began coverage on Local Bounti in a research report on Tuesday. They set a buy rating and a $8.00 price []

The high-growth, high-momentum FAANG stocks were among the stocks enjoying a comeback on Tuesday. Meta Platforms, Amazon, Apple, Netflix and Alphabet all climbed at least 1% during the session. However, they remain well off their highs. Ari Wald, head of technical analysis at Oppenheimer, says he is paying particular attention to the second A in [] The post Watch key levels in Apple shares, trader says appeared first on TECHTELEGRAPH .

Shares of Hercules Capital, Inc. (NYSE:HTGC) saw unusually-high trading volume on Friday . Approximately 17,403 shares changed hands during trading, a decline of 97% from the previous sessions volume of 680,997 shares.The stock last traded at $15.98 and had previously closed at $16.20. HTGC has been the subject of several recent research reports. Oppenheimer restated []

Barnes Group Inc. (NYSE:B) Stock analysts at Oppenheimer decreased their FY2021 earnings per share (EPS) estimates for shares of Barnes Group in a report released on Wednesday, December 15th. Oppenheimer analyst C. Glynn now anticipates that the industrial products company will post earnings of $1.83 per share for the year, down from their previous [] The post Barnes Group Inc. (NYSE:B) to Post FY2021 Earnings of $1.83 Per Share, Oppenheimer Forecasts appeared first on ETF Daily News .

Medtronic (NYSE:MDT) had its price objective reduced by Oppenheimer from $145.00 to $136.00 in a report published on Friday morning, PriceTargets.com reports. They currently have an outperform rating on the medical technology companys stock. Other equities research analysts have also issued reports about the company. UBS Group lifted their price objective on Medtronic from $145.00 []

Oracle (NYSE:ORCL) has been assigned a $94.00 target price by investment analysts at UBS Group in a research report issued to clients and investors on Friday, Borsen Zeitung reports. UBS Groups price target suggests a potential downside of 2.71% from the companys current price. Other equities analysts have also issued reports about the company. Oppenheimer []